TYPE 2 DIABETES MELLITUS (T2DM)

This study tests a new injectable drug called PG-102 in 80 adults with type 2 diabetes. Participants will receive either PG-102, a placebo, or an approved drug (semaglutide) for 24 weeks. The main goal is to see if PG-102 lowers blood sugar (HbA1c) better than placebo, and also c…

This study tests a 12-week nurse-led digital education and support program for young adults (ages 18-45) with type 2 diabetes. The program includes lessons, goal-setting tools, reminders, and messaging with a nurse. Researchers will see if it improves self-care, blood sugar level…

This study tests whether a smartphone app called DIACOACH, which uses artificial intelligence to give personalized health coaching, can help people with type 2 diabetes lower their blood sugar. About 206 adults in Indonesia will either use the app for 12 weeks or receive standard…

This study will test a 3-month lifestyle program for 400 Native Hawaiian and Pacific Islander adults who have conditions like high blood pressure, diabetes, or overweight. The program includes 8 lessons on healthy living and 4 sessions on social factors that affect health. Resear…

This study looks at whether a 6-month drug combination containing pretomanid can safely and effectively treat drug-resistant tuberculosis in people with type 2 diabetes. About 60 patients aged 12 and older will take the same four oral drugs, and researchers will compare outcomes …

This study compares a continuous glucose monitor (CGM) to standard fingerstick checks in 160 adults with type 2 diabetes who use insulin after leaving the hospital. Participants will use either a CGM or fingerstick testing for 12 weeks to see which method better controls blood su…

This study tests whether adding a structured storytelling education program to standard care helps adults with type 2 diabetes improve blood sugar control. About 226 adults with poorly controlled diabetes will either receive usual care or usual care plus three months of narrative…

This study tests whether glimepiride, a standard diabetes medication, can reduce the risk of heart-related death, heart transplant, or worsening heart failure in people with type 2 diabetes and chronic heart failure. About 1,484 adults aged 18-80 will receive either glimepiride o…

This study tests whether taking a daily supplement made from bitter melon extract and snakehead fish powder can help control blood sugar in people with type 2 diabetes. Eighty adults currently on metformin will take either the supplement or a placebo for 4 weeks. The goal is to s…

This study tests whether a diet with adjusted carbohydrate types and amounts can help people with type 2 diabetes control their blood sugar better than a standard diabetes diet. 150 adults aged 35-70 will try both diets for 12 weeks each, with a break in between. The goal is to s…

This study tests whether adding a WhatsApp-based education and counseling program to standard care helps stroke patients with type 2 diabetes improve their healthy habits, blood sugar control, and diabetes knowledge. About 84 participants will be split into two groups: one gets r…

This study tests whether personalized nursing care and education can help adults with type 2 diabetes keep their blood sugar stable and improve their ability to manage the disease. About 72 participants will receive tailored interventions based on a structured nursing system. The…

This study tests whether an intensive lifestyle program—including a low-carb diet, physical activity, sleep routine fixes, and counseling—can help adults with type 2 diabetes achieve remission. 120 participants will follow the program for 6 months, with follow-up at 18 months. Th…

This study will follow 60 people with mild-to-moderate carpal tunnel syndrome, half with type 2 diabetes and half without, to see how well a corticosteroid injection relieves symptoms. Researchers will measure pain, hand function, nerve signals, and ultrasound images before treat…

This study tests whether aromatherapy foot massage can reduce nerve pain in people with type 2 diabetes. About 78 adults will do a 10-minute foot massage three times a week for 4 weeks. Researchers will compare the effects of scented oil versus plain oil to see if the aromatherap…

This study tests a three-part training program for older adults (65+) with diabetes who use insulin. The program teaches CGM technology, data skills, and lifestyle adjustments to improve glucose monitoring and reduce diabetes-related distress. 150 participants will be compared to…

This study will test two new non-invasive devices that measure how well tiny blood vessels work. Researchers will compare 165 adults in five groups: healthy people, those with high blood pressure, those with type 2 diabetes, and those with moderate or severe chronic kidney diseas…

This early study looks at whether transferring healthy gut bacteria (via a stool transplant) can change the gut microbiome in 30 adults with type 2 diabetes and stable coronary artery disease. Participants get the transplant during a colonoscopy and are monitored for 6 months. Th…

This study is a registry that collects long-term safety information from people with type 2 diabetes who have already been treated with the Endogenex System. Researchers will track device- and procedure-related side effects over time. About 500 participants will provide their med…

This study will follow 2,500 adults aged 18–65 in Mexico who do not yet have type 2 diabetes or high blood pressure. Researchers will track their health, lifestyle, and physical fitness over five years to identify what factors increase the risk of developing these conditions. No …

This study observes 30 adults in Mexico who are already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans, heart CT scans, and body composition tests to see how the drug affects knee cartilage, heart fat, and overall body health over one y…

This study looks at how two common artificial sweeteners (sucralose and saccharin) affect blood sugar control and gut bacteria in people with type 2 diabetes. 33 adults will take each sweetener and a placebo for a week, with breaks in between. The goal is to see if these sweetene…